Back
Phathom Pharmaceuticals Stock Price Chart
Sponsored
PHAT
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
57
PHAT
Phathom Pharmaceuticals
Last Price:
18.48
Seasonality Move:
-11.94%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- The current trend is moderately bullish and PHAT is experiencing slight selling pressure.
Phathom Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.78 | Sell |
20-day SMA: | 17.36 | Buy |
50-day SMA: | 14.08 | Buy |
200-day SMA: | 10.56 | Buy |
8-day EMA: | 18.5 | Sell |
20-day EMA: | 17.25 | Buy |
50-day EMA: | 14.92 | Buy |
200-day EMA: | 11.77 | Buy |
Phathom Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.48 | Buy |
Relative Strength Index (14 RSI): | 63.92 | Buy |
Chaikin Money Flow: | -122643 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.13 - 18.75) | Buy |
Bollinger Bands (100): | (9.5 - 15.04) | Buy |
Phathom Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 18.43 while PHAT 8-day simple moving average is 18.78, which is a Sell signal.
- The stock price of PHAT is 18.43 while Phathom Pharmaceuticals 20-day SMA is 17.36, which makes it a Buy.
- Phathom Pharmaceuticals 50-day simple moving average is 14.08 while PHAT share price is 18.43, making it a Buy technically.
- PHAT stock price is 18.43 and Phathom Pharmaceuticals 200-day simple moving average is 10.56, creating a Buy signal.
PHAT Technical Analysis vs Fundamental Analysis
Buy
57
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a Buy
The current Phathom Pharmaceuticals [PHAT] share price is $18.43. The Score for PHAT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
1.26B
Price in USD:
18.43
Share Volume:
1.15M
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
6.07
Buy
57
Phathom Pharmaceuticals (PHAT)
is a Buy
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?
The Phathom Pharmaceuticals stock price is 18.43 USD today. -
Will PHAT stock go up or go down?
Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Phathom Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is not overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 18.43 while PHAT 8-day exponential moving average is 18.50, which is a Sell signal.
- The stock price of PHAT is 18.43 while Phathom Pharmaceuticals 20-day EMA is 17.25, which makes it a Buy.
- Phathom Pharmaceuticals 50-day exponential moving average is 14.92 while PHAT share price is 18.43, making it a Buy technically.
- PHAT stock price is 18.43 and Phathom Pharmaceuticals 200-day simple moving average is 11.77, creating a Buy signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
- PHAT Moving Average Covergence Divergence (MACD) indicator is 1.48, suggesting Phathom Pharmaceuticals is a Buy
- Phathom Pharmaceuticals Relative Strength Index (RSI) is 63.92, which suggest Phathom Pharmaceuticals is overbought
- The Bollinger Bands (25) for Phathom Pharmaceuticals is (14.13 - 18.75), which suggest Phathom Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Phathom Pharmaceuticals is (9.5 - 15.04), which suggest Phathom Pharmaceuticals is a Buy
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.